P11215 (ITAM_HUMAN) Homo sapiens (Human)
Integrin alpha-M UniProtKBInterProSTRINGInteractive Modelling
1152 aa; Sequence (Fasta) ; (Isoform 2)
Available Structures
24 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Integrin alphaM/beta2 ectodomain |
Heteromer P05107; | 100.0 | 1×NAG; 4×CA; 9×NAG; | |||
| Integrin alphaM/beta2 ectodomain in complex with adenylate cyclase toxin RTX751 and M1F5 Fab |
Heteromer P05107; P0DKX7; | 100.0 | 1×NAG; 1×NAG; 33×CA; 11×NAG; | |||
| Structure of alphaMbeta2/Cd11bCD18 headpiece in complex with a nanobody |
Heteromer P05107; | 99.73 | 4×NAG; 2×CA; 1×NAG; | |||
| HADDOCK models of human alphaM I-domain bound to the the N-terminal domain of the cytokine pleiotro… |
Heteromer P21246; | 100 | ||||
| Crystal Structure of A-domain in complex with antibody |
Heteromer | 100 | 8×EDO; 5×GOL; 1×NA; 1×CA; 1×CL; | |||
| Crystal Structure of A-domain in complex with antibody |
Heteromer | 99.47 | 4×EDO; 3×GOL; 1×CA; | |||
| Structure of a complement factor-receptor complex |
Heteromer P01024; | 100 | 1×NAG; 1×NAG; 3×GOL; 2×K; 2×MG; 1×NAG; | |||
| HADDOCK models of active human alphaM I-domain bound to the the C-terminal domain of the cytokine p… |
Heteromer P21246; | 100 | 1×MG; | |||
| Integrin I domain of complement receptor 3 in complex with C3d |
Heteromer P01024; | 100 | 2×NI; | |||
| Crystal structure of human CD11b I-domain (CD11b-I) in complex with Staphylococcus aureus octameric… |
Heteromer Q2FWN9; Q2FWP0; | 100 | 24×DMS; 4×MG; | |||
| MAC-1 I DOMAIN MAGNESIUM COMPLEX | homo-2-mer | 100 | 2×MG; | |||
| MAC-1 I DOMAIN CADMIUM COMPLEX | homo-2-mer | 100 | 3×CD; 2×ACE; | |||
| MAC-1 I DOMAIN METAL FREE | homo-2-mer | 100 | ||||
| INTEGRIN ALPHA M I DOMAIN | monomer | 99.48 | ||||
| INTEGRIN ALPHA M I DOMAIN | monomer | 100 | ||||
| Crystal structure of human Cd11b I domain in P212121 space group | monomer | 99.47 | 7×SO4; 7×GOL; 1×CL; | |||
| Crystal structure of human Cd11b I domain in C121 space group | monomer | 100 | 2×SO4; 10×EDO; | |||
| I-DOMAIN FROM INTEGRIN CR3, MN2+ BOUND | monomer | 100 | 1×MN; | |||
| I-DOMAIN FROM INTEGRIN CR3, MG2+ BOUND | monomer | 100 | 1×MG; | |||
| Structural basis for simvastatin competitive antagonism of complement receptor 3 | monomer | 100 | 1×MG; 1×SIM; | |||
| AN ISOLEUCINE-BASED ALLOSTERIC SWITCH CONTROLS AFFINITY AND SHAPE SHIFTING IN INTEGRIN CD11B A-DOMA… | monomer | 100 | 1×CA; | |||
| INTEGRIN ALPHA M I DOMAIN MUTANT | monomer | 98.91 | 1×MG; | |||
| Structures and Interaction Analyses of the Integrin Alpha-M Beta-2 Cytoplasmic Tails | monomer | 100 | ||||
| Structures and Interaction Analyses of the Integrin Alpha-M Beta-2 Cytoplasmic Tails | monomer | 100 | ||||
8 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7p2d.1.A | monomer | 0.85 | 2×CA; | 99.47 | ||
| 7usl.1.A | monomer | 0.72 | 3×CA; | 100.00 | ||
| 5e6u.1.A | monomer | 0.71 | 1×MG; | 39.02 | ||
| 8zjf.1.B | monomer | 0.60 | 29.71 | |||
| 9deq.1.A | monomer | 0.60 | 23.15 | |||
| 4g1e.1.A | monomer | 0.58 | 22.98 | |||
| 7nxd.1.A | monomer | 0.58 | 25.43 | |||
| 4cak.1.A | monomer | 0.53 | 22.41 | |||
9 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 7p2d.1.A | monomer | 0.85 | 2×CA; | 99.60 | ||
| Isoform 2 | 7usl.1.A | monomer | 0.72 | 3×CA; | 100.00 | ||
| Isoform 2 | 5e6u.1.A | monomer | 0.71 | 1×MG; | 37.16 | ||
| Isoform 2 | 8t2v.1.A | monomer | 0.61 | 23.15 | |||
| Isoform 2 | 8zjf.1.B | monomer | 0.60 | 29.71 | |||
| Isoform 2 | 4g1e.1.A | monomer | 0.59 | 22.98 | |||
| Isoform 2 | 7nxd.1.A | monomer | 0.57 | 25.29 | |||
| Isoform 2 | 6avu.1.A | monomer | 0.53 | 27.51 | |||
| Isoform 2 | 4cak.1.A | monomer | 0.53 | 22.41 | |||